Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
|
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [1] Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma
    Umberto Falcone
    Haiyan Jiang
    Shaheena Bashir
    Richard Tsang
    Vishal Kukreti
    Armand Keating
    Michael Crump
    John Kuruvilla
    Bone Marrow Transplantation, 2018, 53 : 347 - 351
  • [2] Addition of rituximab to TBI/CY improves the outcome of first-line autologous stem cell transplantation for mantle cell lymphoma
    Seyfarth, B
    Boehme, V
    Stuhlmann, R
    Sonnen, R
    Kneba, M
    Schmitz, N
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S6 - S6
  • [3] Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma
    Wang, Yucai
    Larson, Melissa C.
    Kumar, Anita
    Hill, Brian T.
    Bond, David Alan
    Kahl, Brad S.
    Danilov, Alexey Valeryevich
    Merryman, Reid
    Grover, Natalie Sophia
    Tun, Aung M.
    Ayyappan, Sabarish Ram
    Pongas, Georgios
    Portell, Craig Anthony
    Munoz, Javier
    Reagan, Patrick Michael
    Moustafa, Muhamad Alhaj
    Pophali, Priyanka Avinash
    Greenwell, Irl Brian
    Cohen, Jonathon Brett
    Martin, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma
    de Guibert, Sophie
    Jaccard, Arnaud
    Bernard, Marc
    Turlure, Pascale
    Bordessoule, Dominique
    Lamy, Thierry
    HAEMATOLOGICA, 2006, 91 (03) : 425 - 426
  • [5] Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma
    Graf, S. A.
    Stevenson, P. A.
    Holmberg, L. A.
    Till, B. G.
    Press, O. W.
    Chauncey, T. R.
    Smith, S. D.
    Philip, M.
    Orozco, J. J.
    Shustov, A. R.
    Green, D. J.
    Libby, E. N., III
    Bensinger, W. I.
    Pagel, J. M.
    Maloney, D. G.
    Zhou, Y.
    Cassaday, R. D.
    Gopal, A. K.
    ANNALS OF ONCOLOGY, 2015, 26 (11) : 2323 - 2328
  • [6] Autologous stem cell transplantation and rituximab for mantle cell lymphoma
    Capote, F.
    Gonzalez-Barca, E.
    Bergua, J.
    Calvo, J. Fernandez
    Oriol, A.
    Garcia-Boyero, R.
    Ramirez, M.
    Caballero, D.
    Romero, A.
    Perez, E.
    Queizan, J.
    Pascual, M.
    Cantalapiedra, A.
    Giraldo, P.
    Palomera, L.
    Guinot, M.
    Ribera, J.
    Leon, A.
    Gil, J.
    Fernandez-Sevilla, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [7] First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
    Liu, Hailing
    Shi, Xiao
    Fang, Huizi
    Cao, Lei
    Miao, Yi
    Zhao, Xiaoli
    Wu, Wei
    Xu, Wei
    Li, Jianyong
    Fan, Lei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] VR-CAP Alternating with Rituximab and High-Dose Cytarabine: An Effective First-Line Mantle Cell Lymphoma Regimen Prior to Autologous Stem Cell Transplant
    Smith, Stephen D.
    Till, Brian G.
    Cowan, Andrew J.
    Kanan, Sandra L.
    Low, Lauren
    Gopal, Ajay K.
    Press, Oliver W.
    Hill, Brian T.
    Shadman, Mazyar
    BLOOD, 2017, 130
  • [9] Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma
    Romancik, Jason T.
    Allen, Pamela B.
    Waller, Edmund K.
    Chen, Zhengjia
    Valla, Kelly
    Dixon, Kaylan
    Reagan, David J.
    Colbert, Amanda B.
    Rosand, Cecilia
    Palmer, Alexandra
    Flowers, Christopher
    Cohen, Jonathon B.
    BLOOD, 2020, 136
  • [10] Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome
    Dreger, Peter
    Rieger, Michael
    Seyfarth, Baerbel
    Hensel, Manfred
    Kneba, Michael
    Ho, Anthony D.
    Schmitz, Norbert
    Pott, Christiane
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 42 - 49
12345